Emergency department (ED)–based initiation of buprenorphine has been shown to increase engagement in outpatient treatment and reduce the risk of subsequent opioid overdose; however, rates of buprenorphine treatment in the ED and follow-up care for opioid use disorder (OUD) remain low in the U.S. In response to high opioid overdose death rates, the Pennsylvania Department of Human Services (DHS) implemented the Opioid Hospital Quality Improvement Program (O-HQIP) in 2019. The O-HQIP is the first statewide financial incentive program designed to increase engagement in OUD treatment, including buprenorphine treatment, for Medicaid-enrolled patients who have ED encounters. This cohort cohort study of 17, 428 Medicaid-enrolled patients demonstrated that the O-HQIP was associated with an increased initiation of buprenorphine in patients with OUD presenting to the ED. These findings suggest that statewide incentive programs may effectively improve outcomes for patients with OUD.
Published March 24, 2023
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Exploring the Interface Between Birth Registration and Citizenship Determination: A Scoping Study in…
Catalyzing Support for CRVS Improvement – Examples from the Data for Health Initiative
A Guide to Designing Contextualized Civil Registration and Vital Statistics E-Learning Courses
Guide to Developing Standard Operating Procedures (SOPs) for Civil Registration Using a Case-Based…
Building Safe and Healthy Communities
Uncovering the Hidden Risks of PM 2.5 Exposure Among School-Aged Children in Jakarta
Foundations & Futures: Reimagining Public Health in the Artificial Intelligence Era
Strengthening Health Systems to Address Air Pollution in Ethiopia
Policy Brief: Childhood Blood Lead Surveillance in Indonesia – Findings and Policy Recommendations
Impact of Blue Lanes on Road Safety: Crashes, Speed and Motorcyclists’ Perceptions in…